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Abstract
Binary outcomes defined by logical (Boolean) “and” or “or” operations on original continuous and
discrete outcomes arise commonly in medical diagnoses and epidemiological research. In this manuscript,
we consider applying the “or” operator to two continuous variables above a threshold and a binary
variable, a setting that occurs frequently in the modeling of hypertension. Rather than modeling the
resulting composite outcome defined by the logical operator, we present a method that models the original
outcomes thus utilizing all information in the data, yet continues to yield conclusions on the composite
scale. A stratified propensity score adjustment is proposed to account for confounding variables. A
Mantel-Haenszel style combination of strata-specific odds ratios is proposed to evaluate a risk factor. The
benefits of the proposed approach include easy handling of missing data and the ability to estimate the
correlations between the original outcomes. We emphasize that the model retains the ability to evaluate
odds ratios on the simpler and more easily interpreted composite scale. The approach is evaluated by
Monte Carlo simulations. An example of the analysis of the impact of sleep disordered breathing on a
standard composite hypertension measure, based on blood pressure measurements and medication usage,
is included.
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1 Introduction
Binary outcomes based on Boolean operations arise frequently in biomedical practice and
research. We refer to such outcomes as “Boolean outcomes”, from the British mathematician
George Boole who founded the basis for modern computer arithmetic. The principal
example of such an outcome for this manuscript is the standard epidemiologic definition
of hypertension, which requires a systolic blood pressure greater than or equal to 140 mmHg
or a diastolic blood pressure greater than or equal to 90 mmHg or the use of antihypertensive
medications (see Nieto et al., 2000; Peppard et al., 2000; Banks et al., 2006, for example).
This Boolean outcome is defined using two observed continuous outcomes and one binary
outcome. Similarly defined outcomes from logical operators arise in clinical trials, often
referred to as “composite endpoints”. For example, a composite endpoint could be comprised
of all-cause mortality, non-fatal myocardial infraction, and stroke. Using composite endpoints
in clinical trials can potentially increase the overall event rates, reduce the necessary sample
size to achieve a desired statistical power, and reduce the duration of the trials (Quan et al.,
2007).
Model based approaches to analyzing Boolean outcomes typically use a logit link to
associate the effects of covariates to the probability of a success. However, such an
approach disregards the correlation between the original outcomes, a potentially important
and informative component of the data. Moreover, as in the hypertension example, if
the Boolean outcome is either partially or completely comprised of continuous variables,
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important information is lost in the thresholding. In addition, appropriately handing missing
data remains a problem.
To elaborate on the latter point, missing values can cause problems for outcomes created
with logical operators, since informative missingness can be induced in the constructed
outcome, even when the original outcomes are missing completely at random. For example,
consider the fact that a missing value in one outcome, combined with a positive outcome in at
least one of the other outcomes yields a positive Boolean outcome for the “or” operator. This
problem has received some attention since the 1960’s. In particular, maximum likelihood
estimators of cell probabilities in two-dimensional contingency tables with both completely
and partially cross-classified data were considered by Chen and Fienberg (1974) and Hocking
and Oxspring (1974). Williamson and Haber (1994) extended this approach to three-
dimensional contingency tables. In order to estimate the proportion of successes for the
derived outcome with missing values, Li et al. (2007b) proposed four estimators, including
a maximum likelihood estimator. Similarly, Quan et al. (2007) considered treatment
comparisons from composite endpoints comprised of two original components with missing
data.
To address these issues with the prevalent method of analyzing Boolean outcomes, we
propose to jointly model the continuous and binary variables. The proposed approach
overcomes the above shortcomings, while retaining the ability to make odds-ratio conclusions
with respect to probabilities of the Boolean outcome.
Jointly modeling mixed (continuous and categorical) responses has been intensively
studied since the 1990’s. For example, when considering a single continuous and single
binary variable a common approach creates an underlying latent normal variable that, when
3
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thresholded, produces the observed discrete variable (notably, see Albert and Chib, 1993).
An early method to improve the efficiency of related probit models was addressed in Chesher
(1984). The author showed that a fully efficient maximum likelihood estimation of the probit
model with a continuous ancillary outcome can be achieved by a simple two-step procedure,
involving an ordinary least squares and a subsequent probit estimation. Conniffe (1997)
showed that when extra observations are available for the binary outcome, the standard
single-equation estimator of a linear regression for a continuous outcome could be improved
through joint estimation with a probit model.
Although there is no clustering in our motivation data set, clustered/correlated data with
mixed outcomes are common in some fields, such as developmental toxicology. Statistical
methods have been developed for analyzing these data. Probit models for joint modeling
of clustered data comprised of one binary and one continuous response through marginal
and mixed effects models were proposed by Regan and Catalano (1999) and Gueorguieva
and Agresti (2001). Fitzmaurice and Laird (1995) developed regression models for bivariate
discrete and continuous outcomes with clustering using a generalized equation estimation
(GEE) approach. Joint modeling of cluster size, binary and continuous variables was studied
by Gueorguieva (2005). Bayesian latent variable models for clustered mixed outcomes and
associated Markov Chain Monte Carlo sampling algorithms were proposed by Dunson (2000)
and Dunson et al. (2003). Bivariate modeling of clustered continuous and ordered categorical
outcomes was studied in Catalano (1997) and Gueorguieva and Agresti (2006). In addition,
regression models for mixed Poisson and continuous longitudinal data have been developed
by Yang et al. (2007).
In this manuscript, motivated by the definition of hypertension, we consider joint modeling
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of two continuous outcomes and one binary outcome using maximum likelihood and a latent
probit variable structure. However, conclusions are then transferred onto the scale of the
resulting Boolean variable. As such, conclusions remain on the primary scale of interest,
while still capitalizing on the full information contained in the original outcomes. A dilemma
arises in that covariate adjustment renders transforming parameters to the appropriate scale
difficult. Our solution involves combining propensity-score adjusted bins using Mantel-
Haenzsel weighting of odds ratios for the Boolean outcome. This both eases the ability
to adjust for covariates and offers the benefits afforded to propensity score adjustments.
Propensity scores have been used widely in the analysis of observational studies.
Rosenbaum and Rubin (1983) proposed the propensity score as a balancing score to make
subjects in the “treatment” and “control” groups have as similar covariates as possible
and to adjust for observed confounding covariates in observational studies. The propensity
score is defined as the probability of treatment assignment given a vector of covariates. In
randomized studies this probability is a known quantity, while in observational studies the
treatment assignment probability is unknown and must be estimated. Ideally, matching
or subclassifying on the propensity score eliminates further need to consider the observed
covariates. However, this presumes a correctly specified and accurately estimated model
for the probability of treatment assignment (see Drake, 1993, for further discussion). We
note that propensity scores can do nothing in the presence of excessive correlation between
treatment assignment and one or more confounding variables. However, the use of propensity
scores makes this problem explicit, as opposed to linear models, which would compare the
uncomparable treated and untreated groups via unsupported linear extrapolations.
We note that in our application the “treatment” is really disease status (sleep disordered
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breathing), which is not actually or conceptually assignable. Hence we avoid any causal
discussion of our results, noting that propensity scores are frequently used as balancing
mechanisms without reference to causality (see Schneider et al., 2004; Li et al., 2007a, for
other examples).
This paper is organized as follows. In Section 2, we introduce a method to jointly model
two continuous outcomes and one binary outcome. We extend the method to estimate the
effects of treatment and the proportions of Boolean outcome for treated and untreated group
using propensity score method. In Section 3, we highlight the results of a simulation study.
In Section 4, we apply the proposed approach to hypertension. The final section is devoted
to a summary and discussion of directions for future research.
2 Statistical Methods
2.1 Notation
In this section, we define notation for our modeling approach. Let yik, i = 1, . . . , n, k = 1, 2, 3
be outcome k for subject i. We assume that yi1 and yi2 are observed continuous variables
while yi3 is a latent variable for which only a thresholded binary version is observed. For
example yi1 might be systolic blood pressure, yi2 might be diastolic blood pressure, and yi3
might be a latent variable whose thresholded value represents antihypertensive medication
usage. We treat each as conditionally independent normal outcomes with associated covariate
vector Xi = (xi1, xi2, . . . , xip)
′.
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The statistical models of interest are then
yi1 =Xiβ1 + ui12 + ui13 + i1,
yi2 =Xiβ2 + ui12 + ui23 + i2,
yi3 =Xiβ3 + ui13 + ui23 + i3,
where β1,β2,β3 are fixed effect regression parameters to be estimated. The random
components, uijk, are shared Gaussian random intercepts between outcome j and k for
subject i, each having mean zero and variance σ2ujk . As such, these models induce a marginal
unstructured correlation matrix for the three outcomes, forcing non-negative correlations
between all three. This positive constraint causes no problem in data with three outcomes,
because non-negative correlations can always be reduced by changing the sign of one variable
if it is negatively correlated with the other two outcomes. We assume normality of the
error terms, ik ∼ N(0, σ2k) and, for the moment, that all subjects have all three outcomes
observed. The presumption of a common design vector, Xi for all three outcomes is not
necessary, though is relevant in our application.
The implied marginal model is given by:
yi1
yi2
yi3
 ∼ N3


Xi1β1
Xi2β2
Xi3β3
 ,Σ

,
where,
Σ =

σ21 + σ
2
u12
+ σ2u13 σ
2
u12
σ2u13
σ2u12 σ
2
2 + σ
2
u12
+ σ2u23 σ
2
u23
σ2u13 σ
2
u23
σ23 + σ
2
u13
+ σ2u23
 =
 ΣAA ΣAB
ΣBA ΣBB
 .
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Recall that the latent variable, yi3, is not observed. Instead only the binary realization
of whether the variable is above a threshold is observed. We choose zero for the threshold;
that is y∗i3 = I{y3 ≥ 0}. The parameter σ3 is not identified. Standard practice assumes that
σ23 = 1, which implies a conditional probit model for the observed binary outcome. That is,
P (Y ∗i3 = 1 | ui13, ui23,β3,ΣAB,ΣBB)
= P (Yi3 ≥ 0 | ui13, ui23,β3,ΣAB,ΣBB)
= P (Xiβ3 + ui13 + ui23 ≥ −i3 | ui13, ui23,β3,ΣAB,ΣBB)
= Φ(Xiβ3 + ui13 + ui23).
An alternative derivation of this model is obtained by dividing Yi3 by σ3, hence inducing the
conditional probit model for y∗i3. Therefore, under this derivation, the estimated β3 and σ13
and σ23 are interpreted relative to the non-identified σ3.
In our application, the “treatment” is a respiratory disturbance index (RDI, a measure of
severity of sleep-disordered breathing) value above a threshold and we consider a variation
of propensity score stratification to achieve covariate balance and account for observed
confounding variables. The rational for using propensity scores, rather than the original
covariates, is that we intend to estimate the effects of treatment on proportions of the
Boolean outcome (the comparison of the proportions between the treated and untreated
group). However, after controlling these confounding covariates, how to group subjects
for comparison remains a problem when there are continuous confounding covariates and
cut points for grouping may vary from data set to data set. In this case, the propensity
score method provides an convenient way to balance these observed covariates and to
facilitate a simple comparison on the Boolean outcome. The propensity score estimation
can be preformed by a logistic regression models of treatment status on the relevant
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covariates. We bin the estimated propensity scores into five categories. Therefore, we
assume that Xi contains an intercept, a treatment indicator, and indicators of propensity
score strata. Although it is straightforward to allow Xi to contain separate intercepts and
treatment indicators for each of the propensity score strata (interaction terms), driven by
the hypertension data, we do not include such terms. Note that this stratifies the treatment
effect across propensity score classification status. However, it does not stratify the variance
matrix, a point discussed in the data analysis.
2.2 Maximum Likelihood Estimation
For the purposes of fitting, we note that the joint marginal likelihood for the three responses
of subject i can be decomposed as
f(yi1, yi2, yi3 | β1,β2,β3,Σ) = f(yi1, yi2 | β1,β2,ΣAA)f(yi3|yi1, yi2,β1,β2,β3,Σ), (1)
where f is used to denote a generic density. The benefit of such a decomposition is the ability
to separate the latent variable distribution of y3 from the two observed variables. The first
term of (1) is the bivariate marginal normal distribution given previously. The second term
is the conditional density function given by
yi3|yi1, yi2 ∼ N
{
X iβ3 +ΣBAΣ
−1
AA[(yi1, yi2)− (Xiβ1,Xiβ2)]′,ΣBB −ΣBAΣ−1AAΣAB
}
.
Given this formulation, it is easy to then derive the contribution of y∗i3 to the likelihood.
Specifically, we have:
P (Y ∗i3 = 1 | Yi1, Yi2,β1,β2,β3,Σ) = P (Y3i ≥ 0|Yi1, Yi2,β1,β2,β3,Σ) (2)
= Φ
Xiβ3 +ΣBAΣ−1AA[(yi1, yi2)− (Xiβ1,Xiβ2)]′√
ΣBB −ΣBAΣ−1AAΣAB
 .
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Therefore, we can write out the subject-specific contribution to the marginal likelihood for
(yi1, yi2, y
∗
i3) as the product of the marginal bivariate normal likelihood for (yi1, yi2) times
either the Bernoulli probability (2) or the probability of the complement, depending on
whether y∗i3 was a 1 or 0 respectively.
Note that following the simple strategy above, one can calculate the likelihood contri-
bution regardless of the subset of the three observations that was observed. That is, if
only yi1 and y
∗
i3 are observed (hence yi2 is missing), one need only calculate the conditional
distribution of yi1 given yi3 marginalized over the random effects, which then yields the probit
probability of y∗i3 given only yi1. Notationally, let ri1, ri2, ri3 be observed data indicators for
yi1, yi2 and y
∗
i3 respectively. Then the likelihood function with missing values can be written
as
n∏
i=1
f(yi1, yi2, y
∗
i3)
ri1ri2ri3f(yi1, yi2)
ri1ri2(1−ri3)f(yi1, y∗i3)
ri1(1−ri2)ri3f(yi2, y∗i3)
(1−ri1)ri2ri3
f(yi1)
ri1(1−ri2)(1−ri3)f(yi2)(1−ri1)ri2(1−ri3)f(y∗i3)
(1−ri1)(1−ri2)ri3 ,
where f again denotes the appropriate density marginalized over the random effects and
dependence on the parameter values is omitted.
Maximization was performed on this marginal likelihood using quasi-Newton algorithms.
Numerical estimates of the Hessian of the log-likelihood were used to get standard error
estimates.
2.3 Further Modeling Considerations
Generally, when considering Boolean outcomes, practitioners are primarily interested in
the probabilities of the aggregated variables. After estimation, such probabilities can be
calculated post-hoc. For example, for hypertension data one would be interested in the
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probability
h(β1,β2,β3,Σ) = P [(Y1 ≥ 140) ∪ (Y2 ≥ 90) ∪ (Y3 ≥ 0) | β1,β2,β3,Σ] , (3)
where Y1, Y2 and Y3 represent conceptual values of the three variables. Given estimates for
the parameters, and values for the design matrices, this probability is simply a multivariate
normal calculation, with easily calculated standard errors using the delta method via
numerical derivatives. That is, if βˆ1, βˆ2, βˆ3, Σˆ are the ML estimates with inverse observed
information matrix Ω, then we can calculate a confidence interval for the Boolean outcome
using variance estimate
h′(βˆ1, βˆ2, βˆ3, Σˆ)
tΩh′(βˆ1, βˆ2, βˆ3, Σˆ),
where the derivatives, h′, are calculated numerically.
We focus in particular on the instance when the design matrix contains only a treatment
indicator and indicators for propensity score strata. We then use Mantel-Haesnzel style
weighting to combine estimates of the probabilities of the Boolean outcome.
Given the discretized nature of the propensity score strata, one could fit a separate Σ
for each of the J categories. This would correspond to fitting completely separate models
for each strata. However, unless there is evidence to the contrary, we typically retain a
common Σ across propensity score strata. This small concession to parsimony drastically
reduces the number of variance component parameters fit. However, we did investigate
allowing for separate variance matrices for the treated and control groups, as differences in
the relationship between outcomes for the two groups are of primary interest.
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3 Monte Carlo Simulation Study
We conducted a simulation study to investigate the performance of our approach. We
simulated the data from an assumed model motivated by the directed acyclic graph in Figure
1. The outcomes Yij, j = 1, 2, 3 for subject i were generated from a multivariate normal
distribution based on the joint model in Section 2 and covariates X i = (1, Xi1, Xi2, Xi3, Ti).
Here, Xi1 is a confounder that is associated with outcomes and treatment, Ti; Xi2 is only
associated with the original outcomes, but not with the treatment. The variable, Xi3 is only
associated with treatment assignment, but not with outcomes. The first three covariates were
simulated as independent standard normals. The treatment indicator, Ti, was generated from
the logit model logit [p(Ti = 1)] = α0 + α1Xi1 + α2Xi2 +α3Xi3. This set up has been used
in univariate regression problems in Brookhart et al. (2006). Two sets of slope coefficients
β, (−2, 1, 0.5, 0, 1)t, and (−2, 1, 0.5, 0, 2)t were considered; these represent strong
and weak effects of treatment on outcomes. The same slope coefficients were used for all
three outcomes. Similarly, two sets of α = (α0, α1, α2, α3) coefficients, (−1, 1, 0, 1.5)t, and
(−1, 0.5, 0, 1)t were used.
We first fit the simulated data using a correctly specified model to evaluate the convergence
of our estimating algorithms and the performance of the approach. These simulation results
are described in the Appendix. Secondly, we fit the simulated model using propensity scores
estimated by a logistic regression of T on X1 and X3. Hence, the design vector for the
fitted mixed outcome model included a propensity score strata indicator and a treatment
indicator (inclusion of interaction terms is straightforward; however, for simplicity, we do
not consider them here). Five strata were created, as motivated by Cepeda et al. (2003).
We also considered a model where the individual outcomes were combined into a single
12
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Boolean outcome, which was used in a logistic regression model that included an intercept,
a treatment indicator and the indicator terms for the five category propensity score strata.
One thousand subjects were assumed, with three outcomes, two continuous and one binary,
in each simulation. Simulations were repeated one thousand times.
We emphasize that the model used to generate the data is not the propensity score
model fit to each simulated data set. Therefore, true values for the regression parameters
and variance components were not available for comparison. However, we do compare these
fitted parameters with the averaged values from simulations (see Austin, 2007). Let p1 and p0
be these true success probabilities for the treatment and control group, respectively. Hence,
differences, ratios and odds ratios of these probabilities represent treatment effects to be
estimated. Using this approach, we can investigate the feasibility of using subclassification
by propensity score in Boolean outcome analysis.
Table 2 shows the results from jointly modeling two continuous variables and one binary
variable treating propensity score quintile as a categorical variable in the regressions. The
mean observed (unadjusted) p1 is 0.696, and p0 is 0.389. The mean observed (unadjusted)
difference in proportions is 0.307; and the mean observed (unadjusted) OR is 3.61. The
adjusted mean difference in probabilities, p1 − p0, is 0.186, where the fitted probabilities
p1 and p0 are estimated by averaging the fitted stratum-specific probabilities across the
propensity score strata by treatment, from which an ORadj is calculated directly. The Mantel-
Hanszel OR (ORMH) is calculated using the fitted cell frequencies derived from the estimated
regression parameters. The simulated data show an improved performance over strictly
modeling the Boolean outcome (see Appendix). Especially, the confidence interval coverage
rates are much closer to the nominal values. In addition, the treatment effects on Y1 and Y2,
13
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β14, β24, are closer to their true values; while the effect on Y3,β34 shows a slight bias. Note
the standard error for ORMH was also calculated from the estimates from regressions using
numerical derivative. The simulations from other input values yielded similar results (not
shown here). The mean estimated correlation between Y1 and Y2, Y1 and Y3, and Y2 and
Y3 are 0.28, 0.38, 0.38, respectively, compared to the true values 0.17, 0.24, 0.24. However,
recall that the joint models with propensity scores as covariates are actually misspecified
models, so that some bias is expected. However, the relative sizes of three correlations are
close to those of the true values (1:1.36:1.36, compared to 1:1.41:1.41), suggesting that the
correlation is being adequately addressed.
4 Application to the Sleep Heart Health Study
We use data from the multi-center Sleep Heart Health Study (see Quan et al., 1997) as
an illustration. Hypertension (as in Peppard et al., 2000) in a subject is defined as the
presence of a high systolic (greater than or equal to 140 mmHg) or diastolic blood pressure
(greater than or equal to 90 mmHg) measurement or if the subject is taking anti-hypertensive
medications (AHM). Interest lies in the association between sleep-disordered breathing and
hypertension. Sleep-disordered breathing was quantified by the respiratory disturbance
index (RDI), defined as the number of apneas plus hypopneas per hour of sleep, measured
by in-home polysomnography (Gottlieb et al., 1999). A total of 5, 681 of the total 6, 441
subjects had RDI values. Of these, 5, 015 had complete values for race, age, sex, weight,
Epworth Sleepiness Score, body mass index, current smoking (yes=1, no/other=0), hip, neck
circumference, total sleep time, waist, RDI, and at least one of systolic or diastolic blood
pressure or medication. All of the above potentially confounding variables, except blood
14
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pressure and medication use, were used in the estimation of the propensity of having a RDI
in the highest quartile (RDI=1). Here, RDI=1 represented the “treatment” group. The
observed prevalence of hypertension for the low RDI category (RDI=0) was 49%, and 61%
for the high one, yielding an unadjusted odds ratio of 1.64 with a 95% confidence interval of
[1.41, 1.91].
Two-by-two tables derived from the five propensity score strata are shown in Table 3.
The propensity score density of high RDI by RDI group is shown in Figure 2. For the
high RDI group, the mean propensity score was 0.37 versus 0.17 for the low RDI group.
The propensity score adjusted hypertension prevalence rates were 50%, and 57%, for low
and high RDI, respectively, resulting in an overall odds ratio of 1.28. The Mantel Haenzsel
OR based on cell frequencies stratified by propensity score quintile was 1.14 with a 95%
confidence interval of [0.96, 1.34]. The test of homogeneity in ORs by the Mantel-Hanszel
or Breslow-Day method is not statistically significant (p-value=0.136, 0.133, respectively).
Thus a combined OR can be used to summarize the effects of RDI on hypertension across
the propensity score strata. By comparison, the odds ratio for hypertension comparing high
RDI values versus low ones from a logistic regression model of the composite outcome using
standard logistic regression including the confounding variables as linear covariates was 1.07
with a 95% confidence interval of [0.90, 1.28].
The regression coefficients from the joint modeling of systolic blood pressure, diastolic
blood pressure, and taking anti-hypertensive medications with propensity score quintile,
and RDI as covariates are shown in Table 4. The Mantel-Hanszel estimated odds ratio
was 1.13 (with a confidence interval of [0.96, 1.33]); p0adj=0.53, p1adj=0.56, ORadj=1.13.
After adjusting for the propensity score, the dichotomized RDI was not associated with
15
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systolic blood pressure and diastolic blood pressure. However it was statistically significantly
associated with the latent anti-hypertensive medication use.
The estimated correlation between systolic blood pressure and diastolic blood pressure
was 0.41, and between systolic blood pressure and the latent medication use variable was
0.32. Interestingly, the diastolic blood pressure and the latent medication use variable were
much less correlated (estimated as 5.7× 10−7).
5 Discussion
In this manuscript, we considered joint modeling of continuous and discrete variables for
the purpose of evaluating a Boolean outcome. We proposed stratified propensity scores
as a method for solving the practical problem of creating odds-ratio estimates on the
composite scale. Our approach easily handles the missing data problems present in these
settings. In addition, significance of the treatment or disease on the individual outcomes
is performed simultaneously with the analysis of the Boolean outcome. Also, important
covariance estimates are produced to investigate associations between the original outcomes.
We present a random effect structure to produce an unstructured covariance matrix that
is easily maximized while handling the constraints forced by the latent continuous variable
used to model the dichotomous original outcome.
Our simulation studies suggest that this more flexible model can, at times, outperform
working on the Boolean scale in terms of confidence interval coverage performance. We note
that these potential gains come along with the increased flexibility and added information
produced by the model. The application of the proposed approach to hypertension data from
Sleep Heart Health Study provided new insights on the association of RDI and hypertension
16
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and the correlation between systolic blood pressure, diastolic blood pressure, and the use of
anti-hypertensive medications.
For future research it would be interesting to consider more general missing data
mechanisms other than completely at random missingness. Other approaches, such as,
weighted likelihood, multiple imputations (Rubin, 1987) may be used in this setting. In
addition, the effects of missing covariate data on estimation of logically defined outcome is
also of interest. Another possible extension of the joint modeling includes investigating other
correlation structures for random effects with extensions to longitudinal data.
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Appendix
Monte Carlo simulations with propensity score subclassification
Table 1 shows the results from propensity score subclassification using only the composite
data. That is, the original outcomes are discarded once the Boolean outcome is constructed
and the Boolean outcome is cross-tabulated with categorical propensity scores. Displayed
are the true values and the average estimates of the these parameters across simulations.
Without using the propensity score, the mean observed difference in proportions is 0.696−
0.389 = 0.307, and the mean odds ratio is 3.61, between the treated and untreated groups.
After employing propensity score subclassification, the mean adjusted difference is 0.198
and the mean odds ratio is 2.30. The estimated proportions are somewhat close to the true
values, with less than a 1.2% error. The mean asymptotic standard errors of the estimated
proportions and difference in proportions are consistent with their empirical standard
deviations. However, the coverage of the confidence intervals is slightly conservative, mainly
due to the biases in estimation, which may partly be attributable to the fact that the
propensity score does not eliminate all confounding. For ORadj, which is calculated from
estimated p1 and p0, its non-normal distribution might also play a role in un-satisfactory
coverage; the asymptotic standard error is not close to the empirical standard deviation from
the simulations. Similarly, the standard error of ORMH , obtained using the delta method
and Robins method for the variance of log ORMH (Robins et al., 1986), is lower than the
empirical standard deviation too, which partially explains the poor coverage of the confidence
interval for ORMH .
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Table 1: Estimated proportions, difference in proportion, odds ratio, and Mantel-Hanzsel odds ratio, using
5-category propensity score subclassification and observed composite outcome
True Estimate Bias% Std. Dev. Std. Error 95% CI Coverage
p0 0.431 0.427 -0.9 0.022 0.022 0.953
p1 0.618 0.625 1.1 0.047 0.046 0.896
p1 − p0 0.186 0.198 6.5 0.051 0.049 0.917
ORadj 2.16 2.30 6.5 0.522 0.202 0.986
ORMH 2.16 2.29 6.0 0.443 0.155 0.902
βj0 = −2, βj1 = 1, βj3 = 0, j = 1, 2, 3;α0 = −1, α1 = 1, α2 = 0, α3 = 1.5
(σ1, σ2, σ3, σu12, σu12, σu13) = (2, 2, 1, 1, 1, 1).
Mean (SD): p1obs = 0.696(0.025), p0obs = 0.389(0.019),ORobs = 3.61(0.52).
Monte Carlo simulations with correctly specified joint models
In order to examine the performance of the proposed joint modeling approach, we performed
Monte Carlo simulation with original covariates X1, X2, X3, and X4, which were used to
generate the original outcomes, with same or different covariance matrix for the treated and
untreated group, respectively. All regression models were correctly specified in the sense
that data were generated and analyzed using the same set of covariates. Simulations show
that if σ23 is correctly specified, the estimated coefficients and variances and covariates are
unbiased and coverage of 95% CI for each estimate is 93.4%–96.3%. When σ23 is not correctly
specified, the estimated coefficients and variances and covariates related with outcome Y3
were scaled estimates. Since σ2u12 and σ
2
u13
were scaled, σ21 and σ
2
2 are also affected and not
close to their true values. Estimated coefficients and covariances related only to outcomes
Y1 and Y2 (σ
2
u12
) are unbiased. However, regardless of the fixed values for σ23, the coverage of
95%CI covering its scaled mean estimate for each estimate is 93.4%–96.3%. The estimated
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correlation between two outcomes are unbiased, and the estimated probabilities of logically
defined outcome for T = 0 and T = 1 are very close to the observed values. These results
were in agreement with our expectations and indicate that the MLE estimation worked very
well with two continuous variables and one binary variable.
In addition, we examined the performance of the proposed method for data with different
covariance matrix. Suppose the treated and untreated group have the following covariance
matrix
Σ+ I(X4 = 1)

∆11 ∆12 ∆13
∆12 ∆22 ∆23
∆13 ∆32 ∆33
 .
In simulations the data were generated from the model with this covariance matrix. we
set ∆12 and ∆13 equal to 1, all other ∆ij are 0. In joint model regression, for identifiability,
we fixed ∆33 at its true value. Alternatively it could be fixed at any values which make a
valid covariance matrix for the treated group. With correctly specified constraints in the
covariance matrices, all mean regression estimates are very close to their true values, and
the coverage of 95% CI for each parameter is close to the nominal level. The mean standard
errors for parameters are close to standard deviations of their corresponding parameters from
the Monte Carlo simulations. With an estimate and standard error, it is possible to test
whether or not a ∆ij is statistically significant by the Wald test.
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Figure 1: Casual diagram for simulation study
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Table 2: Estimated treatment effects, difference in proportion, odds ratio, and Mantel-Hanzsel odds ratio,
using 5-category propensity score in jointly modeling three outcomes
True Estimate Bias% Std. Dev. Std. Error 95% CI Coverage
β14 1.000 1.064 6.4 0.207 0.215 0.965
β24 1.000 1.055 5.5 0.205 0.215 0.963
β34 1.000 1.288 28.8 0.270 0.277 0.961
p1 − p0 0.186 0.198 6.5 0.027 0.030 0.944
ORadj 2.15 2.26 5.2 0.261 0.283 0.957
ORMH 2.15 2.34 8.8 0.271 0.295 0.971
βj0 = −2, βj1 = 1, βj3 = 0, j = 1, 2, 3;α0 = −1, α1 = 1, α2 = 0, α3 = 1.5
(σ1, σ2, σ3, σu12, σu12, σu13) = (2, 2, 1, 1, 1, 1).
Mean (SD): p1obs = 0.696(0.025), p0obs = 0.389(0.019),ORobs = 3.61(0.52).
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Table 3: Observed hypertension frequencies by RDI and propensity score quintile
PS quintile 1 2 3 4 5
RDI Low High Low High Low High Low High Low High
Hypertension=0 645 9 510 28 436 45 333 92 192 174
Hypertension=1 337 11 425 39 456 67 466 113 320 317
Proportion(%) 34.3 45.0 45.5 58.2 51.1 59.8 58.3 55.1 62.5 64.6
OR 1.57 1.70 1.42 0.88 1.08
Figure 2: Propensity score of high RDI by RDI
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Table 4: Regression coefficients (standard errors) from jointly modeling two continuous
outcomes and one binary outcome with RDI and propensity score quintiles
SBP DBP AHM
Intercept 122.73(0.59) 71.33(0.33) -4.04(0.32)
PS2 6.86(0.83) 0.71(0.47) 1.79(0.37)
PS3 7.75(0.83) 1.24(0.47) 2.29(0.37)
PS4 9.14(0.84) 1.60(0.48) 3.04(0.38)
PS5 10.1(0.90) 2.20(0.51) 3.69(0.42)
RDI 0.15(0.76) 0.11(0.43) 0.66(0.31)
σ11 = 15.2(0.18), σ22 = 5.65(0.22), σ12 = 8.91(0.16),
σ13 = 5.98(0.29), σ23 = 0.60× 10−4(0.42)
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